The role of gut microbiota and drug interactions in the development of colorectal cancer

被引:3
|
作者
Wu, Jinna [1 ]
Xia, Cong [2 ]
Liu, Can [3 ,4 ]
Zhang, Qianshi [2 ]
Xia, Chenglai [3 ,4 ]
机构
[1] Guangzhou Med Univ, Guangdong Engn Res Ctr Oral Restorat & Reconstruct, Guangzhou Key Lab Basic & Appl Res Oral Regenerat, Dept Pharm,Affiliated Stomatol Hosp, Guangzhou, Peoples R China
[2] Dalian Med Univ, Affiliated Hosp 2, Dept Gastrointestinal Surg, Dalian, Peoples R China
[3] Southern Med Univ, Affiliated Foshan Matern & Child Healthcare Hosp, Foshan, Peoples R China
[4] Southern Med Univ, Sch Pharmaceut Sci, Guangzhou, Peoples R China
关键词
gut microbiota; drugs; interactions; colorectal cancer; mechanism of action; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; RENIN-ANGIOTENSIN SYSTEM; ASPIRIN USE; RISK; CHEMOPREVENTION; THERAPY; STATINS; HYPERTENSION; METAANALYSIS; IMPROVEMENT;
D O I
10.3389/fphar.2023.1265136
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The human gut microbiota is a complex ecosystem regulating the host's environmental interaction. The same functional food or drug may have varying bioavailability and distinct effects on different individuals. Drugs such as antibiotics can alter the intestinal flora, thus affecting health. However, the relationship between intestinal flora and non-antibiotic drugs is bidirectional: it is not only affected by drugs; nevertheless, it can alter the drug structure through enzymes and change the bioavailability, biological activity, or toxicity of drugs to improve their efficacy and safety. This review summarizes the roles and mechanisms of antibiotics, antihypertensive drugs, nonsteroidal anti-inflammatory drugs, lipid-lowering drugs, hypoglycemic drugs, virus-associated therapies, metabolites, and dietary in modulating the colorectal cancer gut microbiota. It provides a reference for future antitumor therapy targeting intestinal microorganisms.
引用
收藏
页数:12
相关论文
共 50 条
  • [41] Gut microbiota profiling variated during colorectal cancer development in mouse
    Liu, Jingjing
    Dong, Wei
    Zhao, Jian
    Wu, Jing
    Xia, Jinqiang
    Xie, Shaofei
    Song, Xiaofeng
    [J]. BMC GENOMICS, 2022, 23 (SUPPL 4)
  • [42] Gut microbiota profiling variated during colorectal cancer development in mouse
    Jingjing Liu
    Wei Dong
    Jian Zhao
    Jing Wu
    Jinqiang Xia
    Shaofei Xie
    Xiaofeng Song
    [J]. BMC Genomics, 23
  • [43] Panax notoginseng saponins prevent colitis-associated colorectal cancer development: the role of gut microbiota
    CHEN Ling
    CHEN Man-Yun
    SHAO Li
    ZHANG Wei
    RAO Tai
    ZHOU Hong-Hao
    HUANG Wei-Hua
    [J]. Chinese Journal of Natural Medicines, 2020, 18 (07) : 500 - 507
  • [44] Panax notoginseng saponins prevent colitis-associated colorectal cancer development: the role of gut microbiota
    Chen Ling
    Chen Man-Yun
    Shao Li
    Zhang Wei
    Rao Tai
    Zhou Hong-Hao
    Huang Wei-Hua
    [J]. CHINESE JOURNAL OF NATURAL MEDICINES, 2020, 18 (07) : 500 - 507
  • [45] The Role of Gut Microbiota in Drug Response
    Wilson, I. D.
    Nicholson, J. K.
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2009, 15 (13) : 1519 - 1523
  • [46] Gut Microbiota-MicroRNA Interactions in Intestinal Homeostasis and Cancer Development
    Nikolaieva, Nataliia
    Sevcikova, Aneta
    Omelka, Radoslav
    Martiniakova, Monika
    Mego, Michal
    Ciernikova, Sona
    [J]. MICROORGANISMS, 2023, 11 (01)
  • [47] GUT MICROBIOTA-MEDIATED DRUG-DRUG INTERACTIONS
    Kim, Dong-Hyun
    [J]. DRUG METABOLISM AND PHARMACOKINETICS, 2017, 32 (01) : S18 - S19
  • [48] The gut microbiota, bacterial metabolites and colorectal cancer
    Louis, Petra
    Hold, Georgina L.
    Flint, Harry J.
    [J]. NATURE REVIEWS MICROBIOLOGY, 2014, 12 (10) : 661 - 672
  • [49] Gut Microbiota and Colorectal Cancer Risk Factors
    Feizi, Hadi
    Rezaee, Mohammad Ahangarzadeh
    Ghotaslou, Reza
    Sadrkabir, Mohammad
    Jadidi-Niaragh, Farhad
    Gholizadeh, Pourya
    Taghizadeh, Sepehr
    Ghanbarov, Khudaverdi
    Yousefi, Mehdi
    Kafil, Hossein Samadi
    [J]. CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2023, 24 (08) : 1018 - 1034
  • [50] The gut microbiota, bacterial metabolites and colorectal cancer
    Petra Louis
    Georgina L. Hold
    Harry J. Flint
    [J]. Nature Reviews Microbiology, 2014, 12 : 661 - 672